Phase 2 study of preoperative chemotherapy with nab-paclitaxel and gemcitabine followed by chemoradiation for borderline resectable or node-positive pancreatic ductal adenocarcinoma

OHSU Gastrointestinal Cancer Disease Group

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Phase 2 study of preoperative chemotherapy with nab-paclitaxel and gemcitabine followed by chemoradiation for borderline resectable or node-positive pancreatic ductal adenocarcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences